language_icon
EN
HI

Panacea Biotec Share price

PANACEABIO

386.45

2.70 (0.70%)
NSE
BSE
Last updated on 15 May, 2026 | 15:31 IST
Today's High

390.55

Today's Low

381.00

52 Week Low

292.40

52 Week High

581.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Panacea Biotec Chart

Panacea Biotec Share Key Metrics

Volume
93092.00
Market Cap
2367.04 CR
LTQ@LTP
8@386.45
ATP
384.53
Var Margin
26.1 %
Circuit Range
307-460.5
Delivery %
52.18 %
Value
3.58 CR
ASM/GSM
No
Market Lot
1

Summary

15 May, 2026 | 15:31 को, Panacea Biotec का शेयर प्राइस आज ₹386.45 पर है, जो दिन के लिए 2.70% की 0.70 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹381.00 और ₹390.55 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹292.40 से ₹581.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Panacea Biotec ने 93092 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹61250746 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹38453 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 8,38645 रही। यह स्टॉक ₹307-460.5 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹3.58 CR है। दिन के लिए डिलीवरी परसेंटेज 52.18% रही। इसके अतिरिक्त, Panacea Biotec वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Panacea Biotec Fundamentals

View More
P/E Ratio

0

P/B Ratio

2.85

Div. Yield

0

Sector P/E

71.32

Sector P/B

3.47

Sec. Div. Yield

0.56

Panacea Biotec Resistance and Support

Pivot 385.72

Resistance

First Resistance

389.44

Second Resistance

395.12

Third Resistance

398.84

Support

First Support

380.04

Second Support

376.32

Third Support

370.64

Panacea Biotec Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

72.48%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

1.6%

Domestic Institutional Investors

1.97%

Retail

23.96%

Others

-0.01%

Total Promoters
MAR '26
72.48%

Panacea Biotec Corporate Actions

DateAgenda
2026-02-11Quarterly Results

Panacea Biotec News

Panacea Biotec Limited

Panacea Biotec's wholly-owned subsidiary, Panacea Biotec Pharma Ltd. (PBPL), reported a fire incident at its Oncology Quality Control Laboratory in Baddi. Operations at the facility are temporarily disrupted for 5-7 days. The company states there were no casualties, and adequate insurance covers the facility, with no material financial impact expected.
Apr 30 2026 17:04:00

Panacea Biotec Ltd - 531349 - Intimation Of Fire Incident At Oncology Facility Of The Company'S Wholly Owned Subsidiary, Panacea Biotec Pharma Limited At Baddi, Himachal Pradesh

Panacea Biotec's wholly-owned subsidiary, Panacea Biotec Pharma Ltd, experienced a fire incident at its Oncology Quality Control Laboratory in Baddi, Himachal Pradesh. The incident, caused by a short circuit, has temporarily disrupted facility operations for an estimated 5 to 7 days.
Apr 30 2026 17:04:00

Panacea Biotec Ltd - 531349 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Panacea Biotec received a favorable order from the Income Tax Appellate Tribunal (ITAT), which cancelled a tax demand of Rs.9.16 crore for Assessment Year 2020-21. This decision also deleted the disallowance of expenses amounting to Rs.3.44 crore.
Apr 30 2026 11:04:00
Read More

About Panacea Biotec AboutThe

NSE : 4055  
BSE : 531349  
ISIN : INE922B01023  

Panacea Biotec Ltd. was incorporated as a private limited company in the name and style of Panacea Drugs Private Ltd. on 2nd February 1984. Subsequently the Company became deemed Public limited Company u/s 43A(1 A) of the Companies Act 1956 w.e.f. 30.6.93. The shareholders of the Company in Extra Ordinary General Meeting passed a special resolution on 26.7.93 for deleting the Registration Clause from Articles of Association of the Company u/s 3(1) (iii) of the Companies Act 1956 and as such Company became full fledge public limited Company within the meaning of Section 3 (1) iv) of the Companies Act. Thereafterer the name of the Company hanged to Panacea Biotec Limited on 7th September 1993.The Company has been promoted by Mr. Sosh Kumar Jain who is a pharmacist having about 40 years of experience in the pharmaceutical industry.The Company started its operations in the year 1985 by identifying and importing a group of life saving drugs which were not available in the country for acute diseases like cancer haemophilia cardiac diseases infertility etc. These drugs were imported at an economical price andmade available through a distribution network of stockists all over the country. Having made a significant presence in the markat and after understanding the scope of the product and the latest trend in the medical field the Company made plans to set up its own manufacturing unit in 1989 and thereafter established a marketing team with an already existing distribution network for promotion of ethicalformulations.The promotors of the Company also happened to be the artners in another group company - Radicura Pharma engaged in he line of business of vaccines. Having established its marketing strength in both the group companies i.e. Vaccine Division as well as Pharma marketing the Company decided to make a single entity by merging both the unitsin the year 1992. The company is now utilising the strength of the products and marketing team of both the unit for better performance in the coming years. The Company continue to manufacture the Vaccines under Radicura Pharma with the after now functioning as a division of the Company.The Company started its Export promotion in 1991-92 when product registration in different countries was initiated. During 1993-94 the Comapny exported products worth Rs. 1.00 Crore.Presently the Company is engaged in 4 product lines of Pharmaceuticals. These are :- a) Vaccines b) Biologicals c) formulations d) Natural ProductsThe ethical formulations being promoted is on an all India basis. The Company has a significant presence in different therapeutic Groups. The company has a well established marketing network with dealers spread all over the country. The Company now proposes to expand the capacity of Vaccines Division along with an expansion in the capacities of capsules and suspensions.The company has achieved consistent improvement in rating terms of retail chemist sales out of top 200 Companies in India (Source: ORG Retail Sales Rating) out of companies promoting products ethically.Year March 1993 March 1994Rating 187 153Out of 200 200

Read More

Panacea Biotec Management

NamePosition
Ankit JainCompany Secretary and Compliance Officer
Rajesh JainChairman & Managing Director
View More

Panacea Biotec FAQs

Panacea Biotec शेयर का खरीद मूल्य 386.45 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Panacea Biotec शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Panacea Biotec शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 0 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Panacea Biotec शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.85 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Panacea Biotec शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.47 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Panacea Biotec का मार्केट कैप 2367.04 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Panacea Biotec शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 581.00 और 292.40 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost